BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7929254)

  • 1. Inactivation of human anaphylatoxin C5a and C5a des-Arg through cleavage by the plasminogen activator activity of a human fibrosarcoma cell line.
    Higazi A al-R ; Barghouti II
    J Biol Chem; 1994 Oct; 269(41):25529-33. PubMed ID: 7929254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiloride Reduces Urokinase/Plasminogen-Driven Intratubular Complement Activation in Glomerular Proteinuria.
    Isaksson GL; Hinrichs GR; Andersen H; Bach ML; Weyer K; Zachar R; Henriksen JE; Madsen K; Lund IK; Mollet G; Bistrup C; Birn H; Jensen BL; Palarasah Y
    J Am Soc Nephrol; 2024 Apr; 35(4):410-425. PubMed ID: 38254266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
    Gerard C; Hugli TE
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg.
    Kew RR; Webster RO
    J Clin Invest; 1988 Jul; 82(1):364-9. PubMed ID: 3392213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2.
    Perides G; Noring R; Klempner MS
    Biochem Biophys Res Commun; 1996 Feb; 219(3):690-5. PubMed ID: 8645243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
    Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
    J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylatoxin signaling in human neutrophils. A key role for sphingosine kinase.
    Ibrahim FB; Pang SJ; Melendez AJ
    J Biol Chem; 2004 Oct; 279(43):44802-11. PubMed ID: 15302883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.
    Perez HD; Chenoweth DE; Goldstein IM
    J Clin Invest; 1986 Dec; 78(6):1589-95. PubMed ID: 3782473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of Gc globulin (vitamin D binding protein) to C5a or C5a des Arg is not necessary for co-chemotactic activity.
    Kew RR; Mollison KW; Webster RO
    J Leukoc Biol; 1995 Jul; 58(1):55-8. PubMed ID: 7616106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the targeting of complement anaphylatoxin C5a using a mixed L-RNA/L-DNA aptamer.
    Yatime L; Maasch C; Hoehlig K; Klussmann S; Andersen GR; Vater A
    Nat Commun; 2015 Apr; 6():6481. PubMed ID: 25901944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
    Thorsen S; Müllertz S; Suenson E; Kok P
    Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased survival of human breast cancer cells expressing HER2/neu on in vitro incubation with an anti-HER2/neu antibody fused to C5a or C5a desArg.
    Fuenmayor J; Perez-Vazquez K; Perez-Witzke D; Penichet ML; Montano RF
    Mol Cancer Ther; 2010 Aug; 9(8):2175-85. PubMed ID: 20682652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an inhibitor of tissue-type plasminogen activator-mediated fibrinolysis in human neutrophils. A role for defensin.
    Higazi AA; Barghouti II; Abu-Much R
    J Biol Chem; 1995 Apr; 270(16):9472-7. PubMed ID: 7721874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nerve growth factor-gamma activates soluble and receptor-bound single chain urokinase-type plasminogen activator.
    Wolf BB; Vasudevan J; Henkin J; Gonias SL
    J Biol Chem; 1993 Aug; 268(22):16327-31. PubMed ID: 8393859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of granulocytes and C5a in myocardial response to zymosan-activated serum.
    Stahl GL; Fletcher MP; Amsterdam EA; Longhurst JC
    Am J Physiol; 1991 Jul; 261(1 Pt 2):H29-37. PubMed ID: 1677537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the interaction of human C5a and C5a des Arg with human monocytes and neutrophils: flow cytometric and chemotaxis studies.
    Yancey KB; Lawley TJ; Dersookian M; Harvath L
    J Invest Dermatol; 1989 Feb; 92(2):184-9. PubMed ID: 2493055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of plasminogen activation by glycosylphosphatidylinositol-anchored urokinase.
    Lee SW; Ellis V; Dichek DA
    J Biol Chem; 1994 Jan; 269(4):2411-8. PubMed ID: 8300567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
    Oppermann M; Götze O
    Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1-mediated stimulation of prostaglandin E production is without effect on plasminogen activator activity in human granulosa lutein cell cultures.
    Hurwitz A; Lavy Y; Finci-Yeheskel Z; Milwidsky A; Shimonovitz S; Yagel S; Adashi EY; Laufer N; Mayer M
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3018-24. PubMed ID: 7559890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.